Lightcast Discovery Ltd

Lightcast Discovery Ltd, hailing from Cambridge, UK, is a holding company with an active status, established six years ago in 2019. The company boasts substantial assets, reported at £17,430,602, and operates from a real address in Cambridge. Eight directors manage the business, though no owners are officially listed—likely one of the directors holds the shares. It has a stellar 5.0 Google rating based on a single review. Lightcast Discovery regularly imports and exports optical and medical tools and devices, with 76 months of import activity and 3 months of export activity, the last of which occurred in November 2024.

The company’s website reveals a focus on advanced single-cell functional analysis technology. Lightcast Discovery develops a “Luminary Programme” platform, aiming to analyze single-cell interactions and functional dynamics at scale. They offer a flexible platform for direct interrogation of single cells, enabling research across various disciplines, including drug discovery. The website highlights use cases like biomolecule secretion, cell-cell interactions, and targeted cell killing, showcasing the platform’s versatility. They even publish white papers to advance knowledge in the field.

Financially, Lightcast Discovery Ltd’s recent performance presents a mixed picture. While cash and cash equivalents dropped significantly by 56% to £11,000,000, and net assets decreased by 43% to £16,000,000, debtors surged by 46% to £5,500,000, suggesting improved collection of outstanding payments. Creditors also increased by 13% to £2,300,000. The company’s substantial assets are offset by a significant loss of £17,000,000. The lack of employee numbers (zero reported) indicates a lean operation, and the absence of an auditor (likely exempt due to size) means the figures are unaudited. The company’s substantial asset base suggests a solid foundation, but the losses and declining cash reserves raise concerns about its financial sustainability. The company’s focus on cutting-edge biotechnology research and its high-value technology platform may be contributing to these financial pressures, as research and development can be costly.

Registered in England/Wales under the registration number 11830666, with a registered address at CB3 0FA, United Kingdom, Cambridge, Cambs, Broers Building, 21 Jj Thomson Avenue.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.